top of page
News and insights
VascVersa secures new equity investment
VascVersa, the advanced therapeutics company developing next-generation treatments to regenerate the micro-vasculature of the retina, today announced that it has secured new equity funding from its existing shareholders.
2 days ago2 min read
bottom of page